Interview with Biopact CEO Kurt Swogger
Equifund
October 17, 2020
This past Thursday we sat down with Kurt Swogger, CEO and co-founder of Biopact CT for an in-depth interview. If you are a current investor in the company,
Menu
This guide is brought to you by Equifund, LLC.
If you have money saved in a retirement account – like 401k, 403b, IRA, or Roth IRA – your investment options are likely restricted to things like stocks, bonds, and mutual funds.
But according to ProPublica, wealthy Americans have been using their retirement accounts to invest in Pre-IPO investments to create a tax advantaged fortune!
The most notable example being the founder of PayPal – and now billionaire venture capitalist – Peter Thiel.
According to the same ProPublica article Thiel started a Roth IRA in 1999 with assets that at the time were worth less than $2,000. Those assets are now valued at $5 billion.
How did he do it?
It all has to do with this little-known account that “unlocks” your retirement assets.
For the full details, read our free guide called Pre-IPO Retirement Accounts: How to Invest in Pre-IPO Investments With a Self-Directed IRA
Yours for investing equality,
Jordan Gillissie – CEO
Equifund
This past Thursday we sat down with Kurt Swogger, CEO and co-founder of Biopact CT for an in-depth interview. If you are a current investor in the company,
In this session, we’ll walk you through our comprehensive, step-by-step guide to performing basic due diligence. The goal of Phase 2 is to convert “Marketing Qualified Leads” (generated in Phase 2) into an “Investment Qualified Lead” (IQL).
On this call, Jake takes a deep dive into Pre-IPO investing, why you may want to consider investing in them, the mistakes investors make, and how Equifund looks at opportunities.
This webinar is designed to help you understand and answer one of the most important questions a pre-IPO investor has to answer: “what do I do once the company goes public?”
By submitting your email address you will receive access to this report and a free subscription to Equifund’s private investment newsletter. You can unsubscribe at any time and read more about our privacy policy here.
Proprietary devices that could revolutionize spinal surgery and greatly improve success rates, reduce pain, and lower costs.
Over 20 patents have been issued to protect the company's technologies.
Just received FDA clearance for their next-generation KG2 spinal fusion technology.
The next 8 slides will allow us to process your investment. Note that these next steps are a legal requirement – Thank you for your patience and financial support of this investment opportunity. Jordan Gillissie – CEO
Before we execute the investment, it’s important for us to make sure you’re comfortable and knowledgeable in early stage investing. We want to make sure that you:
We are currently upgrading our system. If you click submit and the process does not continue in a few seconds, please refresh this page manually, and click Invest Now again and you should be moved on to the next step.
Please wait a few minutes while we create your account. An email will be sent to you shortly to confirm your admittance. Should the email be delivered to your spam or promotions folder, we recommend you move it to your inbox and mark Equifund as a safe sender.
If you have not received the email in 5 minutes, please click here to have it resent.
Questions? Our customer service team is always here to help – 1-866-338-3004
This content is for Equifund Members only.
Simply fill out the form below and get instant access:
Or sign-up using one of your existing social accounts…
